Trial site
Vancouver General Hospital
- 87running trials
- 32closed trials
The trials here
What the 119 trials at this site are about, from their registry records.
- Conditions
- Stroke13 trials
- Coronary artery disease11 trials
- Atrial fibrillation9 trials
- Multiple myeloma7 trials
- Heart failure6 trials
- Spinal cord injury5 trials
- COPD4 trials
- Idiopathic pulmonary fibrosis4 trials
- Type 1 diabetes4 trials
- Acute myeloid leukaemia3 trials
- Amyloidosis3 trials
- Aortic stenosis3 trials
- and 35 more
- Phase
- Phase 334 trials
- Phase 29 trials
- Phase 1/27 trials
- Phase 14 trials
- Phase 44 trials
- Phase 2/33 trials
- Early phase 11 trial
- Status
- Recruiting38 trials
- Active, not recruiting36 trials
- Completed27 trials
- Not yet recruiting12 trials
- Terminated4 trials
- Enrolling by invitation1 trial
- Withdrawn1 trial
- Lead sponsor
- University of British Columbia18 trials
- Janssen Research & Development, LLC6 trials
- Boehringer Ingelheim5 trials
- Cardiology Research UBC5 trials
- Eli Lilly and Company4 trials
- and 59 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism
Recruiting
Recruiting
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed)
Not yet recruiting
Recruiting
Evaluating Treatment Strategies for p53 Mutant Oral Cancer and Oral Cancer Precursors
Not yet recruiting
Recruiting
Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial
Not yet recruiting
Neuromodulation Strategies for Treatment-Resistant Essential Tremor Using Chronos™ DBS
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes
Active, not recruiting
Restrictive Fluid Management In Liver Transplantation (REFIL) - Pilot
Recruiting
MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study
Recruiting
"SCRIBBLE" Spinal Cord Injury Blood Biomarker Longitudinal Evaluation
Active, not recruiting
Showing 50 of 87.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke5 recruiting
- Coronary artery disease4 recruiting
- Heart failure3 recruiting
- Spinal cord injury3 recruiting
- Acute lymphoblastic leukaemia2 recruiting
- Acute myeloid leukaemia2 recruiting
- Atrial fibrillation2 recruiting
- Childhood cancers2 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- COPD2 recruiting
- Deep vein thrombosis and pulmonary embolism2 recruiting
- Essential tremor2 recruiting
- Obesity2 recruiting
- Type 1 diabetes2 recruiting
- Amyloidosis1 recruiting
- Aortic stenosis1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Crohn's disease1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Head and neck cancer1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Liver and biliary tract cancer1 recruiting
- Liver cirrhosis1 recruiting
- Mantle cell lymphoma1 recruiting
- Melanoma1 recruiting
- Multiple myeloma1 recruiting
- Myocarditis1 recruiting
- Ovarian cancer1 recruiting
- Peripheral artery disease1 recruiting
- Type 2 diabetes1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Pulsed Field or Cryoballoon Pulmonary Vein Isolation for Atrial Fibrillation in Heart Failure
Completed
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Completed
Rehabilitation for Functional Memory Symptoms After Concussion
Completed
Terminated
Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial
Withdrawn
Terminated
Completed
Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia
Completed
Standardized Invasive Hemodynamics for Elevated Gradients Post TAVR (DISCORDANCE TAVR)
Completed
RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department
Completed
Characterizing Hemorrhage in Acute Spinal Cord Injury With MRI
Completed
Mobilizing Early Management of Mental Health Complications After Mild Traumatic Brain Injury
Completed
Completed
Recruiting
Completed
Completed
POLESTAR Trial - An International Multi-center Early Discharge TAVI Program
Completed
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Completed
Completed
Completed
HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial
Terminated
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation
Completed
Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke
Recruiting
Selinexor and Backbone Treatments of Multiple Myeloma Patients
Completed
Terminated
Ultrasound Detection and Characterization of Subclinical Hypertrophy in Diabetes
Completed
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Completed
Completed
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Site data: ClinicalTrials.govUpdated 17 Nov 2026